Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Full Day's HansardDownload Full Day's Hansard    View Or Save XMLView/Save XML

Previous Fragment    Next Fragment
Tuesday, 9 November 1976


Mr Neil (ST GEORGE, NEW SOUTH WALES) asked the Minister for Health, upon notice:

Why is it necessary for the drug Mogadon to be prescribed in small quantities thus necessitating frequent visits to a doctor and increased costs to Medibank.


Mr Hunt - The answer to the honourable member's question is as follows:

In recommending that the maximum quantity of Mogadon available as a pharmaceutical benefit be 25 tablets, the Pharmaceutical Benefits Advisory Committee was in agreement with the National Health and Medical Research Council that the continuous use of sleeping tablets (such as Mogadon) is not generally desirable. The Committee considers that the maximum quantity of 25 is adequate, in most instances, to establish a sleep pattern.

It is recognised that for some patients the maximum quantity of 25 tablets may not be sufficient and provision exists to cover such cases whereby a doctor may, if he considers it to be in his patient's interest, apply to the Director of Health in his State for authority to prescribe a quantity in excess of the listed maximum.







Suggest corrections